BrandonMichaelHuffmanMD

Oncology • Boston, MA

Gastrointestinal Cancer

Medical Oncologist

Join to view full profile

Dr. Huffman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Huffman's full profile

Already have an account?

Office
450 Brookline Ave
Boston, MA 02215
Phone+1 617-632-3000

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2020 - 2023
Mayo Clinic College of Medicine and Science (Rochester)Chief Residency, Internal Medicine, 2019 - 2020
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2015 - 2018
University of Missouri-Columbia School of MedicineClass of 2015

Certifications & Licensure

MA State Medical License 2020 - 2026
MN State Medical License 2016 - 2020
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

ZN-c3 + Gemcitabine in Pancreatic Cancer Start of enrollment: 2023 Nov 16
Recruiting
Phase 2
Roles: Sponsor-Investigator, Principal Investigator, Contact

Publications & Presentations

PubMed

Circulating Tumor DNA as a Prognostic Biomarker for Recurrence in Patients With Locoregional Esophagogastric Cancers With a Pathologic Complete Response.
Eric Michael Lander, Vasily N Aushev, Brandon M Huffman, Diana Hanna, Punashi Dutta
JCO Precision Oncology. 2024-12-01
Clinical and Genomic Features of Classical and Basal Transcriptional Subtypes in Pancreatic Cancer.
Harshabad Singh, Joanne Xiu, Kevin S Kapner, Chen Yuan, Raja R Narayan
Clinical Cancer Research. 2024-11-01
A Phase 1 Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal Cancer.
Brandon M Huffman, Osama E Rahma, Kevin Tyan, Yvonne Y Li, Anita Giobbie-Hurder
Cancer Immunology Research. 2024-09-30

Lectures

Validation of lymphocyte to monocyte ratio in resected small bowel adenocarcinoma as a predictor of survival.
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

Zentalis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational UpdatesNovember 9th, 2022
Natera Releases New Clinical Data at ESMO 2021 in Gastroesophageal Cancer and Uveal MelanomaSeptember 17th, 2021

Professional Memberships

Alpha Omega Alpha Honor Medical Society - AOA
Member
American College of Physicians - ACP
Member
American Society of Clinical Oncology - ASCO
Member